IP Library Granted Patent US 12,076,485
Granted Patent B2
US 12,076,485 · App. 17/572,494 · Granted Sep 3, 2024

Ventilation mask

Inventors: Michael J. Pedro (Windham, NH); Thomas M. Reilly (Tucson, AZ); Ryan G. Redford (Tucson, AZ); David M. Kane (Tucson, AZ)
Assignee: SunMed Group Holdings, LLC
A61M16/0616A61B5/097A61M16/085A61M16/208A61B5/0836A61B5/6803A61M16/01A61M16/12A61M2202/0208A61M2202/0225A61M2230/432
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,076,485
App. No.
17/572,494
Granted
Sep 3, 2024
Kind
B2
Abstract

A nasal mask has exhalation scoop fixed adjacent a lower portion of mask, adapted to overlie an upper lip of a patient when the mask is worn. The mask includes ports for sampling flow of CO 2 expelled from the mouth and nose of the patient to the end-tidal CO 2 port, and a pressure-based flow resistor for balancing flow of CO 2 expelled from the mouth and the nose of the patient.

Claims (26)

1. A nasal mask comprising:

an inner surface forming a nasal chamber;

a ventilation port that extends from an upper portion of the nasal mask in a first direction;

an end-tidal CO 2 port that extends from the upper portion of the nasal mask and comprises an opening adjacent a lower portion of the nasal mask; and

an exhalation scoop fixed adjacent the lower portion of the nasal mask and adapted to overlie an upper lip of a patient when the nasal mask is worn;

wherein the opening is located behind the exhalation scoop for sampling CO 2 expelled from a mouth of the patient, and the exhalation scoop is formed of a material that is flexible relative to a material that defines the nasal chamber such that the exhalation scoop is adapted to be folded back in the first direction toward the nasal chamber to permit access to the mouth of the patient.

2. The nasal mask of claim 1 , wherein the end-tidal CO 2 port extends from the upper portion of the nasal mask in the first direction.

3. The nasal mask of claim 1 , wherein the end-tidal CO 2 port comprises another opening located in the nasal chamber to underlie a nare of the patient for sampling exhaled CO 2 expelled from a nose of the patient.

4. The nasal mask of claim 1 , wherein the ventilation port is configured to connect with any of an anesthesia machine, a ventilation machine, or a hyperinflation bag.

5. The nasal mask of claim 1 , further comprising an oxygen port configured to connect with an oxygen source for supplying oxygen to the nasal chamber.

6. The nasal mask of claim 5 , wherein the oxygen port extends from the upper portion of the nasal mask in the first direction.

7. The nasal mask of claim 1 , wherein the material of the exhalation scoop is formed of a material having a Shore 00 Durometer Hardness of 0020 to 0050.

8. The nasal mask of claim 1 , wherein the material of the exhalation scoop is formed of a material having a Shore A Hardness selected from 2-10 or 3-7.

9. The nasal mask of claim 1 , further comprising a groove in an outer surface of the nasal mask, wherein the exhalation scoop comprises a lip configured to fit in the groove.

10. The nasal mask of claim 1 , wherein the exhalation scoop is integrally formed with the nasal mask.

11. The nasal mask of claim 1 , wherein the exhalation scoop is configured to be folded around an axis that extends in a second direction, and wherein the second direction is transverse relative to the first direction.

12. A method for ventilating a patient, comprising:

providing a nasal mask having an inner surface forming a nasal chamber, a ventilation port that extends from an upper portion of the nasal mask in a first direction, an end-tidal CO 2 port that extends from the upper portion of the nasal mask and comprises an opening adjacent a lower portion of the nasal mask, and an exhalation scoop fixed adjacent the lower portion of the nasal mask and adapted to overlie an upper lip of the patient when the nasal mask is worn, such that the opening is located behind the exhalation scoop;

connecting the ventilation port to any of an anesthesia machine, a ventilation machine, or a hyperinflation bag;

folding the exhalation scoop back in the first direction toward the nasal chamber to permit access to a mouth of the patient; and

monitoring end-tidal CO 2 by sampling exhaled CO 2 expelled from the mouth of the patient into the opening.

13. The method of claim 12 , monitoring end-tidal CO 2 by sampling CO 2 expelled from a nare of the patient into another opening of the end-tidal CO 2 port located in the nasal chamber.

14. The method of claim 12 , further comprising connecting an oxygen port of said nasal mask to an oxygen source for supplying oxygen to the nasal chamber of the nasal mask.

15. The method of claim 12 , wherein folding the exhalation scoop back in the first direction comprises folding the exhalation scoop around an axis that extends in a second direction, and wherein the second direction is transverse relative to the first direction.

16. The method of claim 12 , further comprising unfolding the exhalation scoop in a second direction away from the nasal chamber to permit access to the mouth of the patient, wherein the second direction is opposite to the first direction.

17. The method of claim 12 , further comprising connecting the end-tidal CO 2 port of the nasal mask to a gas sampling device.

Assignments (10)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS Recorded Nov 25, 2024
From: MACQUARIE CAPITAL FUNDING LLC
To: MACQUARIE PF SERVICES LLC
Reel/Frame 069439/0448 →
SECURITY INTEREST Recorded Jun 29, 2023
From: SUNMED GROUP HOLDINGS, LLC
To: MACQUARIE CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 064164/0730 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2023
From: REVOLUTIONARY MEDICAL DEVICES, INC.
To: SUNMED GROUP HOLDINGS, LLC
Reel/Frame 063822/0169 →
PARTIAL TERMINATION AND RELEASE OF SECURITY INTEREST RECORDED AT 060363/0460, 6/13/2022. Recorded May 3, 2023
From: BANK OF AMERICA, N.A.
To: VYAIRE MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 211, INC.; VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 063528/0973 →
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (060187/0171) Recorded May 2, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: VYAIRE MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 211, INC. (AS SUCCESSOR IN INTEREST TO CAREFUSION 207, INC.); VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 063516/0384 →
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (060363/0915) Recorded May 2, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: VYAIRE MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 211, INC. (AS SUCCESSOR IN INTEREST TO CAREFUSION 207, INC.); VYAIRE MEDICAL CONSUMABLES LLC
Reel/Frame 063516/0067 →
PATENT SECURITY AGREEMENT (2ND LIEN) Recorded Jun 13, 2022
From: VYAIRE MEDICAL, INC.; CIEL MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 207, INC. (F/K/A CAREFUSION 207, INC.); VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 060363/0915 →
SECURITY INTEREST Recorded Jun 13, 2022
From: VYAIRE MEDICAL, INC.; CIEL MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 207, INC. (F/K/A CAREFUSION 207, INC.); VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC,
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 060187/0171 →
FIRST LIEN SECURITY AGREEMENT Recorded Jun 13, 2022
From: VYAIRE MEDICAL, INC.; CIEL MEDICAL, INC.; REVOLUTIONARY MEDICAL DEVICES, INC.; VITAL SIGNS, INC.; VYAIRE MEDICAL 207, INC. (F/K/A CAREFUSION 207, INC.); VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 060363/0460 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2022
From: PEDRO, MICHAEL J.; REILLY, THOMAS M.; REDFORD, RYAN G.; KANE, DAVID M.
To: REVOLUTIONARY MEDICAL DEVICES, INC.
Reel/Frame 059565/0948 →
Continuity (6)
Continuation 16333215
Provisional Application 62510192 · May 23, 2017
Provisional Application 62467808 · Mar 6, 2017
Provisional Application 62425371 · Nov 22, 2016
Provisional Application 62394405 · Sep 14, 2016
Related Publication 20220126047A1 · Apr 28, 2022